Immunic IMUX
Immunic hosts PMS R&D Day webinar
Item 7.01 Investor disclosure
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193805-26-001432
- Hosts Progressive Multiple Sclerosis R&D Day webinar on Nov 5, 2026
- Presentation attached as Exhibit 99.1
- Forward-looking statements included in the presentation
Written from the 8-K on EDGAR. Check the filing before you rely on it.
Similar companies
Same SIC code (2834) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.
- Anixa Biosciences ANIX public float $85M, Apr 30, 2025, over 18 months old
- Filana Therapeutics FLNA public float $87M, Jun 30, 2025
- Oramed Pharmaceuticals ORMP public float $78M, Jun 30, 2025
- GENELUX GNLX public float $89M, Jun 30, 2025
- Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025
